T-cell type lymphoproliferative disease of granular lymphocytes (LDGL) is equipped with a phenotypic pattern typical of effector cytotoxic cells

Leukemia Research

Volumn 31, Issue 3, 2007, Pages 371-377

  Baesso, Ilenia ^a,b,c   Pavan, Laura ^a,b,c   Boscaro, Elisa ^a,b,c   Miorin, Marta ^a   Facco, Monica ^a,b,c   Trentin, Livio ^a,b,c   Agostini, Carlo ^a,b,c   Zambello, Renato ^a,b,c   Semenzato, Gianpietro ^a,b,c  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

CTLs; GLs; KIRs; NCRs; NK CTLs; T cell lymphoproliferative disease of granular lymphocytes

Indexed keywords

CD3 ANTIGEN; CD94 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR;

AGED; ARTICLE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; LARGE GRANULAR LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

AGED; ANTIGENS, CD3; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MALE; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 33846112659     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.06.020     Document Type: Article

References (31)

1. Oshimi K., Yamada O., Kaneko T., et al. Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7 (1993) 782-788
2. Semenzato G., Zambello R., Starkebaum G., Oshimi K., and Loughran Jr. T.P. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 89 (1997) 256-260
3. Lamy T., and Loughran T.P. Large granular lymphocyte leukemia. Cancer Contr 5 (1998) 25-33
4. Zambello R., Falco M., Della Chiesa M., et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 102 (2003) 1797-1805
5. Orange J.S., and Ballas Z.K. Natural killer cells in human health and disease. Clin Immunol 118 (2006) 1-10
6. Cambiaggi A., Orengo A.M., Meazza R., et al. The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function. Blood 87 (1996) 2369-2375
7. Zambello R., Trentin L., Facco M., et al. Analysis of the T cell receptor in the lymphoproliferative disease of granular lymphocytes: superantigen activation of clonal CD3+ granular lymphocytes. Cancer Res 55 (1995) 6140-6145
8. Nash R., McSweeney P., Zambello R., Semenzato G., and Loughran Jr. T.P. Clonal studies of CD3- lymphoproliferative disease of granular lymphocytes. Blood 81 (1993) 2363-2368
9. Epling-Burnette P.K., Painter J.S., Chaurasia P., et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103 (2004) 3431-3439
10. Epling-Burnette P.K., and Loughran Jr. T.P. Survival signals in leukemic large granular lymphocytes. Semin Hematol 40 (2003) 213-220
11. Spits H., Yssel H., Leeuwenberg J., and De Vries J.E. Antigen-specific cytotoxic T cell and antigen-specific proliferating T cell clones can be induced to cytolytic activity by monoclonal antibodies against T3. Eur J Immunol 15 (1985) 88-91
12. Oshimi K., Shinkai Y., Okumura K., Oshimi Y., and Mizoguchi H. Perforin gene expression in granular lymphocyte proliferative disorders. Blood 75 (1990) 704-708
13. Sottini A., Bettinardi A., Quiros-Roldan E., et al. Evidence for antigenic selection of large granular lymphocytes in a patient with Wiskott-Aldrich syndrome. Blood 86 (1995) 2240-2247
14. Kasten-Sportes C., Zaknoen S., Steis R.G., Chan W.C., Winton E.F., and Waldmann T.A. T-cell receptor gene rearrangement in T-cell large granular leukocyte leukemia: preferential V alpha but diverse J alpha usage in one of five patients. Blood 83 (1994) 767-775
15. Kothapalli R., Bailey R.D., Kusmartseva I., Mane S., Epling-Burnette P.K., and Loughran Jr. T.P. Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 22 (2003) 33-39
16. van Baarle D., Kostense S., van Oers M.H., Hamann D., and Miedema F. Failing immune control as a result of impaired CD8+ T-cell maturation: CD27 might provide a clue. Trends Immunol 23 (2002) 586-591
17. Hamann D., Roos M.T., and van Lier R.A. Faces and phases of human CD8 T-cell development. Immunol Today 20 (1999) 177-180
18. Biassoni R., Cantoni C., Pende D., et al. Human natural killer cell receptors and co-receptors. Immunol Rev 181 (2001) 203-214
19. Moretta L., Biassoni R., Bottino C., et al. Human NK cells and their receptors. Microbes Infect 4 (2002) 1539-1544
20. Liu J.H., Wei S., Lamy T., et al. Blockade of Fas-dependent apoptosis by soluble Fas in LGL leukemia. Blood 100 (2002) 1449-1453
21. Zambello R., Berno T., Cannas G., et al. Phenotypic and functional analyses of dendritic cells in patients with lymphoproliferative disease of granular lymphocytes (LDGL). Blood 106 (2005) 3926-3931
22. Osuji N., Matutes E., Catovsky D., Lampert I., and Wotherspoon A. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol 29 (2005) 935-941
23. Lamy T., and Loughran Jr. T.P. Clinical features of large granular lymphocyte leukemia. Semin Hematol 40 (2003) 185-195
24. Morice W.G., Kurtin P.J., Leibson P.J., Tefferi A., and Hanson C.A. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120 (2003) 1026-1036
25. Vitale M., Falco M., Castriconi R., et al. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur J Immunol 31 (2001) 233-242
26. Mingari M.C., Moretta A., and Moretta L. Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. Immunol Today 19 (1998) 153-157
27. Uhrberg M., Valiante N.M., Young N.T., Lanier L.L., Phillips J.H., and Parham P. The repertoire of killer cell Ig-like receptor and CD94/NKG2A receptors in T cells: clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J Immunol 166 (2001) 3923-3932
28. Lundell R., Hartung L., Hill S., Perkins S.L., and Bahler D.W. T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules. Am J Clin Pathol 124 (2005) 937-946
29. Hoffmann T., De Libero G., Colonna M., et al. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type. Br J Haematol 110 (2000) 525-536
30. Bigouret V., Hoffmann T., Arlettaz L., et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94/NKG2C-E and NKD2D killer cell receptors. Blood 101 (2003) 3198-3204
31. Moretta L., Romagnani C., Pietra G., Moretta A., and Mingari M.C. NK-CTLs, a novel HLA-E-restricted T-cell subset. Trends Immunol 24 (2003) 136-143